Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Lohi

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Alimentary Pharmacology & Therapeutics|October 20, 2007
Increasing prevalence of coeliac disease over timeS Lohi, K Mustalahti, K Kaukinen, et al.
Blood Cancer Journal|September 9, 2017
In silico and preclinical drug screening identifies dasatinib as a targeted therapy for T-ALLS Laukkanen, T Grönroos, P Pölönen, et al.
Leukemia|February 28, 2014
Novel activating STAT5B mutations as putative drivers of T-cell acute lymphoblastic leukemiaM Kontro, H Kuusanmäki, S Eldfors, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Alimentary Pharmacology & Therapeutics|October 20, 2007
Increasing prevalence of coeliac disease over timeS Lohi, K Mustalahti, K Kaukinen, et al.
Blood Cancer Journal|September 9, 2017
In silico and preclinical drug screening identifies dasatinib as a targeted therapy for T-ALLS Laukkanen, T Grönroos, P Pölönen, et al.
Leukemia|February 28, 2014
Novel activating STAT5B mutations as putative drivers of T-cell acute lymphoblastic leukemiaM Kontro, H Kuusanmäki, S Eldfors, et al.
Pageof 3